Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Shohei, Mishima"'
1
Akademický článek
Stroke classification and treatment support system artificial intelligence for usefulness of stroke diagnosis
Autor: Nobukazu Miyamoto, Yuji Ueno, Kazuo Yamashiro, Kenichiro Hira, Chikage Kijima, Naoki Kitora, Yoshihiko Iwao, Kayo Okuda, Shohei Mishima, Daisuke Takahashi, Kazuto Ono, Mika Asari, Kazuki Miyazaki, Nobutaka Hattori
Publikováno v: Frontiers in Neurology, Vol 14 (2023)
Background and aimsIt is important to diagnose cerebral infarction at an early stage and select an appropriate treatment method. The number of stroke-trained physicians is unevenly distributed; thus, a shortage of specialists is a major problem in so
Externí odkaz: https://doaj.org/article/10c379eab9ba47338659f9e0d1eac680
Zobrazit plný text záznamu
4
Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
Autor: Yusuke, Takayama, Jun, Yano, Ren, Seike, Shohei, Mishima, Hiroyasu, Shoda
Publikováno v: Anticancer Research. 42:4805-4812
Many patients with advanced lung cancer develop brain metastasis (BM); however, few reports confirming the efficacy of immune checkpoint inhibitors (ICIs) plus chemotherapy in non-small cell lung cancer (NSCLC) patients with symptomatic BM have been
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7fb1abb8e882ab8f7b2a557722a748
https://doi.org/10.21873/anticanres.15985
Zobrazit plný text záznamu
7
Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors
Autor: Takashi Nakamura, Yuki Fukushiro, Yusuke Takayama, Shohei Mishima, Hiroyasu Shoda, Ken Masuda
Publikováno v: In Vivo
Background/aim Chronic obstructive pulmonary disease coexisting with non-small-cell lung cancer (NSCLC) was reported to be associated with a longer progression-free survival (PFS) in patients treated with immune checkpoint inhibitors (ICIs). In the p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac06df37d8604c3291d135576376e14
https://doi.org/10.21873/invivo.12280
Zobrazit plný text záznamu
8
Akademický článek
The Cannabinoid 1–Receptor Silent Antagonist O-2050 Attenuates Preference for High-Fat Diet and Activated Astrocytes in Mice
Autor: Sei Higuchi, Keiichi Irie, Shohei Mishima, Maiko Araki, Makiko Ohji, Atsunori Shirakawa, Yoshiharu Akitake, Kiyoshi Matsuyama, Kenji Mishima, Kenichi Mishima, Katsunori Iwasaki, Michihiro Fujiwara
Publikováno v: Journal of Pharmacological Sciences, Vol 112, Iss 3, Pp 369-372 (2010)
Endocannabinoids have been shown to activate reward-related feeding and to promote astrocytic differentiation. We investigated whether high-fat diet (HFD) intake produced a preference for HFD via an endocannabinoid-dependent mechanism. In the conditi
Externí odkaz: https://doaj.org/article/f44a738a89634a5ab4701c47c7671d7e
Zobrazit plný text záznamu
10
Akademický článek
Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences.
Autor: Sei Higuchi, Keiichi Irie, Ryuji Yamaguchi, Mai Katsuki, Maiko Araki, Makiko Ohji, Kazuhide Hayakawa, Shohei Mishima, Yoshiharu Akitake, Kiyoshi Matsuyama, Kenji Mishima, Kenichi Mishima, Katsunori Iwasaki, Michihiro Fujiwara
Publikováno v: PLoS ONE, Vol 7, Iss 6, p e38609 (2012)
In this study, we examined alterations in the hypothalamic reward system related to high-fat diet (HFD) preferences. We previously reported that hypothalamic 2-arachidonoylglycerol (2-AG) and glial fibrillary acid protein (GFAP) were increased after
Externí odkaz: https://doaj.org/article/6054f09cce2a4cc28d444008b97511cf
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje